Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Familial antithrombin III deficiency

J H Winter, A Fenech, W Ridley

    The Quarterly Journal of Medicine
    |January 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Novel Human Acute Ischemic Stroke Blood Clot Analogs for In Vitro Thrombectomy Testing.

    AJNR. American journal of neuroradiology·2021
    Same author

    The Relationship Between Cerebral Reperfusion And Regional Expression Of Matrix Metalloproteinase-9 In Rat Brain Following Focal Cerebral Ischemia.

    Neuroscience·2020
    Same author

    Prevention and Treatment of Thrombosis.

    Journal of the Royal College of Physicians of London·2019
    Same author

    Animal Models of Focal Cerebral Ischaemia and Haemorrhagic Transformation: Considerations in Experimental Stroke Study Design.

    Current vascular pharmacology·2017
    Same author

    Evaluation of the use of rotational thromboelastometry in the assessment of FXI deficency.

    Haemophilia : the official journal of the World Federation of Hemophilia·2017
    Same author

    Evaluation of the use of global haemostasis assays to monitor treatment in factor XI deficiency.

    Haemophilia : the official journal of the World Federation of Hemophilia·2016

    Antithrombin III deficiency significantly increases the risk of venous thromboembolic disease. This study details three Scottish families with this deficiency, reviewing its characteristics and management.

    Area of Science:

    • Biochemistry
    • Hematology
    • Genetics

    Background:

    • Antithrombin III is a key inhibitor of blood coagulation.
    • Deficiency in Antithrombin III leads to a high risk of venous thromboembolic disease.
    • Understanding Antithrombin III's role is crucial for managing thrombotic disorders.

    Purpose of the Study:

    • To describe three Scottish families with Antithrombin III deficiency.
    • To review existing literature on Antithrombin III deficiency.
    • To discuss the molecular, clinical, and therapeutic aspects of Antithrombin III deficiency.

    Main Methods:

    • Clinical case descriptions of three families.
    • Literature review of reported Antithrombin III deficiency cases.
    • Analysis of Antithrombin III properties, function, and assay methods.

    Related Experiment Videos

    Main Results:

    • Detailed characterization of Antithrombin III deficiency in three Scottish families.
    • Compilation of molecular abnormalities, inheritance patterns, and clinical presentations.
    • Review of diagnostic assays and therapeutic strategies.

    Conclusions:

    • Antithrombin III deficiency is a heritable condition predisposing to thrombosis.
    • Comprehensive understanding aids in diagnosis and management.
    • Antithrombotic drugs and Antithrombin III concentrates are therapeutic options.